BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5495 related articles for article (PubMed ID: 26724797)

  • 1. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced live-birth rates after IVF/ICSI in women with previous unilateral oophorectomy: results of a multicentre cohort study.
    Lind T; Holte J; Olofsson JI; Hadziosmanovic N; Gudmundsson J; Nedstrand E; Lood M; Berglund L; Rodriguez-Wallberg K
    Hum Reprod; 2018 Feb; 33(2):238-247. PubMed ID: 29211889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.
    Ji J; Liu Y; Tong XH; Luo L; Ma J; Chen Z
    Hum Reprod; 2013 Oct; 28(10):2728-34. PubMed ID: 23887075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM; Humaidan P; Alviggi C
    Hum Reprod; 2021 Jul; 36(8):2157-2169. PubMed ID: 34179973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
    Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS; Warzecha AK; Nielsen MV; Andersen CY; Holt MD; Petersen MR; Sopa N; Zedeler A; Englund AL; Pinborg A; Grøndahl ML; Skouby SO; Macklon NS
    Hum Reprod; 2023 Nov; 38(11):2154-2165. PubMed ID: 37699851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
    Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
    Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF/ICSI cycles.
    Montoya-Botero P; Martinez F; Rodríguez-Purata J; Rodríguez I; Coroleu B; Polyzos NP
    Hum Reprod; 2020 Apr; 35(4):826-836. PubMed ID: 32163564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
    Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers.
    Munch EM; Sparks AE; Zimmerman MB; Van Voorhis BJ; Duran EH
    Hum Reprod; 2017 Jul; 32(7):1402-1409. PubMed ID: 28472321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.
    Bosdou JK; Venetis CA; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Mar; 34(3):491-505. PubMed ID: 30689865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
    Oudshoorn SC; van Tilborg TC; Eijkemans MJC; Oosterhuis GJE; Friederich J; van Hooff MHA; van Santbrink EJP; Brinkhuis EA; Smeenk JMJ; Kwee J; de Koning CH; Groen H; Lambalk CB; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2506-2514. PubMed ID: 29121269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles.
    Zhou J; Wang B; Hu Y; Sun H
    Arch Gynecol Obstet; 2017 Nov; 296(5):1005-1012. PubMed ID: 28879481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 275.